cholestyramine resin has been researched along with puromycin aminonucleoside in 2 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (puromycin aminonucleoside) | Trials (puromycin aminonucleoside) | Recent Studies (post-2010) (puromycin aminonucleoside) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 874 | 3 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamond, JR; Hanchak, NA; Karnovsky, MJ; McCarter, MD | 1 |
| Hattori, T; Ito, M; Nagamatsu, T; Suzuki, Y | 1 |
2 other study(ies) available for cholestyramine resin and puromycin aminonucleoside
| Article | Year |
|---|---|
Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.
Topics: Animals; Cholesterol; Cholestyramine Resin; Diet; Disease Models, Animal; Glomerular Filtration Rate; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats.
Topics: Animals; Anticholesteremic Agents; Azathioprine; CD4-Positive T-Lymphocytes; Cholestyramine Resin; Clofibrate; Cyclosporine; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Glomerulus; Leukocytes, Mononuclear; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-2 | 1996 |